Alpha-Adrenergic Antagonist clinical trials
How each study uses Alpha-Adrenergic Antagonist is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Alpha-Adrenergic Antagonist studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 2
Boston Scientific Corporation (1) · Pedro de Figueiredo Buchalla (1) · Samsung Medical Center (1)
Often tested with
Tested in the same studies.
5-alpha reductase inhibitors (1) · Anti-Inflammatory Agents, Non-Steroidal (1)
Studies
Open first, then newest update. How each study uses Alpha-Adrenergic Antagonist is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Alpha-Blockers Prior to Ureteral Access Sheath Placement in Flexible Ureteroscopy: A Randomized Prospective StudyRecruitingPhase 4Pedro de Figueiredo BuchallaNCT07124299Written as Experimental: Alpha-blocker groupHow we know
- REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active MenActive, not recruitingNot applicableBoston Scientific CorporationNCT04838769Written as alpha blocker and 5-alpha reductase inhibitorHow we know
- The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic HyperplasiaWithdrawnPhase 4Samsung Medical CenterNCT00687388Written as alpha-blocker and NSAIDHow we know